Estradiol Patch
Product Images NDC 0378-3349

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 0378-3349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Estradiol Structural Formula (Image 01)

FDA Label Image

Transdermal Parts (Image 02)

Transdermal Parts (Image 02)
The text appears to be a schematic or a diagram of a product or material that consists of Foam backing with adhesive layer, a polyester film layer, an acrylate adhesive matrix layer, and a protective liner containing Estradiol. Therefore, it is most likely a product or material used in medical or health-related applications that releases Estradiol.*
FDA Label Image

Figure 1 Mean Serum 17β-estradiol Concentrations Vs. Time Profile Following Application Of A 7.75 Cm2 Transdermal Patch And Application Of A 15.5 Cm2 Estradiol Transdermal System Continuous Delivery (once-weekly) Patch (Image 03)

FDA Label Image

Figure 2 Observed Mean (± S.e.) Estradiol Serum Concentrations For A One Week Application Of The Estradiol Transdermal System Continuous Delivery (once-weekly) (31 Cm2) To The Abdomen And Buttocks Of 38 Postmenopausal Women (Image 04)

FDA Label Image

Figure 3 Mean Percent Change From Baseline In Lumbar Spine (a-p View) Bone Mineral Density By Treatment And Time Last Observation Carried Forward (Image 05)

FDA Label Image

Figure 4 Mean Percent Change From Baseline In Total Hip By Treatment And Time Last Observation Carried Forward (Image 06)

FDA Label Image

Instructions For Use Figure A (Image 07)

Instructions For Use Figure A (Image 07)
Estradiol is a form of estrogen. The text appears to be an image, not readable by software.*
FDA Label Image

Instructions For Use Figures B And C (Image 08)

FDA Label Image

Instructions For Use Figures D And E (Image 09)

FDA Label Image

Instructions For Use Figures F And G (Image 10)

FDA Label Image

Instructions For Use Figure H (Image 11)

FDA Label Image

Estradiol Transdermal System, Usp 0.025 mg/day Carton Label (Image 12)

FDA Label Image

Estradiol Transdermal System, Usp 0.0375 mg/day Carton Label (Image 13)

Estradiol Transdermal System, Usp 0.0375 mg/day Carton Label (Image 13)
This is a product description of a transdermal system called Estradiol, meant for weekly continuous delivery. The content of the system includes hemihydrate propylus and adhesives. The usual dosage and prescribing information can be found on the attached document. The product needs to be stored at a controlled room temperature and kept out of reach of children. The manufacturer is mentioned at the end - Mylan, and a couple of other brand names - Tamisgen and Eatadel Transdamal Systrm, are also mentioned.*
FDA Label Image

Estradiol Transdermal System, Usp 0.05 mg/day Carton Label (Image 14)

Estradiol Transdermal System, Usp 0.05 mg/day Carton Label (Image 14)
This is a description for a medication called "Estradiol Transdermal System, USP", which is used only for transdermal use. It is a continuous delivery system that is intended to be worn for 7 days and, every 155 o system contains estradiol USP. It contains active ingredients such as propylenes and it is made up of sy, povidone, ahyhous colkidl lcon, dioids, presouresenshivaaerlc adheshe, copolymer toam, polyeterfim, and brown nk. The product is to be kept away from children at 20°-25°C (68°-77°F), and it is for immediate use once the pouch is removed. Usual dosage is according to a physician's prescription.*
FDA Label Image

Estradiol Transdermal System, Usp 0.06 mg/day Carton Label (Image 15)

Estradiol Transdermal System, Usp 0.06 mg/day Carton Label (Image 15)
This is a product description of Estradiol Transdermal System, a USP Continuous Delivery method used for continuous delivery of estradiol for once-weekly use. The system contains 16.0 o system contans ssracol, USP. It is for transdermal use only and should be kept out of the reach of children. The recommended dosage is mentioned in the attached prescribing information and after removing it from the pouch when ready for use. This system should be stored at 20°C -25°C.*
FDA Label Image

Estradiol Transdermal System, Usp 0.075 mg/day Carton Label (Image 16)

FDA Label Image

Estradiol Transdermal System, Usp 0.1 mg/day Carton Label (Image 17)

Estradiol Transdermal System, Usp 0.1 mg/day Carton Label (Image 17)
This is a description of a transdermal system for continuous delivery of Estradiol, a female hormone. The system is intended for use once a week by women and each system contains a certain amount of Estradiol. The system should be used only for transdermal use and stored at room temperature. The text also provides instructions on dosage and storage, as well as warnings to keep all drugs out of the reach of children. The manufacturer is identified as Mylan Pharmaceuticals Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.